Hello all, can you please share what is your pharmacy policy turn-around time for routine and for STAT medications? How successful are you at meeting that target consistently?
Thank you,
Daniel

Hello,
Our current standard concentration for fentanyl continuous infusion is 50mcg/mL. We have nurses spike the 50mL vial and place such in a locked box attached to the IV pole as the medication is infused. Patients typically consume one or more vials. Recently Pharmacy has been told that the rubber stoppers fall into the vial but not all the time. Has anyone else experienced a similar situation ? Does anyone have a remedy for this problem?
Comments and suggestions welcome.
Regards
Maria T. Russo PharmD
Director of Pharmacy

Our institution is heavily focusing on metrics and we cannot seem to come up with an appropriate medication safety metric. I don't personally like reported number of ADEs as this a voluntary system. We have our compliance rates for barcoding and smart pumps but want something that shows our level of busyness and can measure what the medication safety portion of our team is doing. What safety metrics are other institutions doing? For reference we are a 208 bed community, teaching institution. Thank you!

Hi

We have a Senior Clinical Pharmacist/MSO position available. Located in beautiful southern California, we are a safety net healthy of 2 acute care hospitals and 11 CHCs throughout Riverside County. We are an enterprise pharmacy department so your responsibilities would include both the acute care and clinic environments. We are also an EPIC member and a Vizient member.
Email me if you are interested or would like more information.

Greg

As part of our CQI with Medication Reconciliation, I wanted to focus on medications that are to be communicated during discharge from an acute care setting that should be discontinued. An example would be an NSAID that was on a home med hx after an acute HF episode.

I am interested in other institutions' guidelines, protocols, policies, etc. for bivalirudin, especially for pediatric use. Would anyone have something to share?

I am interested in other institutions' guidelines, protocols, policies, etc. for bivalirudin, especially for pediatric use. Would anyone have something to share?

Hello All-

Our Healthcare system is in the process of evaluating insulin pen vs. vial for the short-acting, long acting insulin.

What does everyone use at their sites?

Natalie Zilban, PharmD, MPH, BCGP
Pharmacy Safety and Medication Officer
Memorial Healthcare System
Ft. Lauderdale, FL 33311

Greetings! I am hoping to connect with organizations/facilities that serve the oncology population and have successfully eliminated injectable promethazine. The biggest area of concern/debate among some of our facilities is treatment of breakthrough nausea/vomiting in the oncology population.

I appreciate any information/pearls in this area others are willing to share. Also if you have a subject matter expert that would be willing to be contacted briefly by our team that would be appreciated!

Are patients required to be in negative pressure rooms for tobi nebs? Are there any other precautions around the administration of tobi nebs for inpatients at your facilities?